Care at Hand raises $560K for its healthcare analytics platform
The company provides an easy way for direct care (non-clinical) workers to export valuable "red flag" health related events to Case Managers.
InfoBionic raises $8M for its remote monitoring device
The funds will be used to commercialize the second generation of the MoMe Kardia device that transmits a continuous feed of the patient's heart rhythm.
Garmin Forerunner 25 GPS running watch announced
The wearable is expected to begin shipping in Q3 and will have a suggested retail price of $169.99 or $199.99 when bundled with a heart rate monitor.
Zest Health raises $6M Series A for its health price-transparency service
The company, which helps consumers make more informed and cost-effective decisions, will use the funds to accelerate growth and expand its market share.
FDA clears PhysIQ’s Personalized Physiology Analytics Engine Software
It is the first FDA-cleared product to receive the code PLB: Automated calculation of a summary index based on several individual measured vital sign inputs.
Parks: 25% of consumers have privacy concerns with connected health devices
The industry not only needs to ensure it has strong security measures in place but also that users are aware of the steps they are taking to protect their data.
Virtua to offer Teladoc-powered telehealth services
Southern New Jersey's largest health system will launch its telemedicine offering is planned in fall 2015, following technical implementation and training.
Wear Your Health challenge launched to tackle chronic disease
The challenge is looking to identify wearable technology concepts and mobile solutions that address behavior management in patients with chronic disease.
Board Vitals raises $1.1M for its medical boards prep service
The company offers a platform of prep tools to help residents, attending physicians and fellows fare better on the medical boards.
Peak, Cambridge University team-up over a brain training game
The training module is based on the Wizard memory game, developed by Professor Barbara Sahakian and Tom Piercy at Cambridge's Department of Psychiatry.